Global Pulmonary Hypertension Drugs Market Research Report 2015-2025
- HEY3817788
- 75 Pages
- April 2020
- Healthcare
The global Pulmonary Hypertension Drugs market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Prostacyclin and prostacyclin analogs
Endothelin receptor antagonists (ERAs)
Phosphodiesterase-5 (PDE-5) inhibitors
Soluble guanylate cyclase (sGC) stimulators
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Bayer
GSK
Arena
Actelion
Pfizer
United Therapeutics
Gilead Sciences
Lung Biotechnology PBC
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Early-stage Drug Candidates (Phase I & Phase II)
Late-stage Drug Candidates (Phase III & Registration Phase)
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Pulmonary Hypertension Drugs Picture
1.1.2 Specifications
Table Product Specifications of Pulmonary Hypertension Drugs
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Pulmonary Hypertension Drugs
Table Global Pulmonary Hypertension Drugs Market by Type, 2011-2022 (USD Million)
1.2.1.1 Prostacyclin and prostacyclin analogs
Table Prostacyclin and prostacyclin analogs Overview
1.2.1.2 Endothelin receptor antagonists (ERAs)
Table Endothelin receptor antagonists (ERAs) Overview
1.2.1.3 Phosphodiesterase-5 (PDE-5) inhibitors
Table Phosphodiesterase-5 (PDE-5) inhibitors Overview
1.2.1.4 Soluble guanylate cyclase (sGC) stimulators
Table Soluble guanylate cyclase (sGC) stimulators Overview
1.2.2 by Application
Table Application Segment of Pulmonary Hypertension Drugs
Table Global Pulmonary Hypertension Drugs Market by Application, 2011-2022 (USD Million)
1.2.2.1 Early-stage Drug Candidates (Phase I & Phase II)
Table Early-stage Drug Candidates (Phase I & Phase II) Overview
1.2.2.2 Late-stage Drug Candidates (Phase III & Registration Phase)
Table Late-stage Drug Candidates (Phase III & Registration Phase) Overview
1.2.3 by Regions
Table Global Pulmonary Hypertension Drugs Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Pulmonary Hypertension Drugs
2.2 Upstream
Table Cost of Pulmonary Hypertension Drugs
Figure Manufacturing Process of Pulmonary Hypertension Drugs
2.3 Market
2.3.1 SWOT
Figure SWOT of Pulmonary Hypertension Drugs
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Pulmonary Hypertension Drugs
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Pulmonary Hypertension Drugs
3.4 Market Entry
Table Market Entry of Pulmonary Hypertension Drugs
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Prostacyclin and prostacyclin analogs Market, 2013-2018
Figure Prostacyclin and prostacyclin analogs Market Size and Growth, 2015-2019 (USD Million)
Figure Prostacyclin and prostacyclin analogs Market Size and Growth, 2015-2019 (in Volume)
Table Prostacyclin and prostacyclin analogs CAGR by Revenue and Volume, 2015-2019
4.1.2 Endothelin receptor antagonists (ERAs) Market, 2013-2018
Figure Endothelin receptor antagonists (ERAs) Market Size and Growth, 2015-2019 (USD Million)
Figure Endothelin receptor antagonists (ERAs) Market Size and Growth, 2015-2019 (in Volume)
Table Endothelin receptor antagonists (ERAs) CAGR by Revenue and Volume, 2015-2019
4.1.3 Phosphodiesterase-5 (PDE-5) inhibitors Market, 2013-2018
Figure Phosphodiesterase-5 (PDE-5) inhibitors Market Size and Growth, 2015-2019 (USD Million)
Figure Phosphodiesterase-5 (PDE-5) inhibitors Market Size and Growth, 2015-2019 (in Volume)
Table Phosphodiesterase-5 (PDE-5) inhibitors CAGR by Revenue and Volume, 2015-2019
4.1.4 Soluble guanylate cyclase (sGC) stimulators Market, 2013-2018
Figure Soluble guanylate cyclase (sGC) stimulators Market Size and Growth, 2015-2019 (USD Million)
Figure Soluble guanylate cyclase (sGC) stimulators Market Size and Growth, 2015-2019 (in Volume)
Table Soluble guanylate cyclase (sGC) stimulators CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 Prostacyclin and prostacyclin analogs Market Forecast, 2020-2025
Figure Prostacyclin and prostacyclin analogs Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Prostacyclin and prostacyclin analogs Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Prostacyclin and prostacyclin analogs CAGR by Revenue and Volume, 2012-2024
4.2.2 Endothelin receptor antagonists (ERAs) Market Forecast, 2020-2025
Figure Endothelin receptor antagonists (ERAs) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Endothelin receptor antagonists (ERAs) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Endothelin receptor antagonists (ERAs) CAGR by Revenue and Volume, 2012-2024
4.2.3 Phosphodiesterase-5 (PDE-5) inhibitors Market Forecast, 2020-2025
Figure Phosphodiesterase-5 (PDE-5) inhibitors Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Phosphodiesterase-5 (PDE-5) inhibitors Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Phosphodiesterase-5 (PDE-5) inhibitors CAGR by Revenue and Volume, 2012-2024
4.2.4 Soluble guanylate cyclase (sGC) stimulators Market Forecast, 2020-2025
Figure Soluble guanylate cyclase (sGC) stimulators Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Soluble guanylate cyclase (sGC) stimulators Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Soluble guanylate cyclase (sGC) stimulators CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Early-stage Drug Candidates (Phase I & Phase II) Market, 2013-2018
Figure Early-stage Drug Candidates (Phase I & Phase II) Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Early-stage Drug Candidates (Phase I & Phase II) CAGR by Revenue and Volume, 2015-2019
5.1.2 Late-stage Drug Candidates (Phase III & Registration Phase) Market, 2013-2018
Figure Late-stage Drug Candidates (Phase III & Registration Phase) Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Late-stage Drug Candidates (Phase III & Registration Phase) CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Early-stage Drug Candidates (Phase I & Phase II) Market Forecast, 2020-2025
Figure Early-stage Drug Candidates (Phase I & Phase II) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Early-stage Drug Candidates (Phase I & Phase II) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Early-stage Drug Candidates (Phase I & Phase II) CAGR by Revenue and Volume, 2020-2025
5.2.2 Late-stage Drug Candidates (Phase III & Registration Phase) Market Forecast, 2020-2025
Figure Late-stage Drug Candidates (Phase III & Registration Phase) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Late-stage Drug Candidates (Phase III & Registration Phase) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Late-stage Drug Candidates (Phase III & Registration Phase) CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Pulmonary Hypertension Drugs Market by Vendors, 2015-2019 (in Volume)
Table Global Pulmonary Hypertension Drugs Market Share by Vendors, 2015-2019 (USD Million)
Table Global Pulmonary Hypertension Drugs Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure Pulmonary Hypertension Drugs Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Bayer
Table Bayer Profile List
Table Microecological Modulator Operating Data of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 GSK
Table GSK Profile List
Table Microecological Modulator Operating Data of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Arena
Table Arena Profile List
Table Microecological Modulator Operating Data of Arena (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Actelion
Table Actelion Profile List
Table Microecological Modulator Operating Data of Actelion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Pfizer
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 United Therapeutics
Table United Therapeutics Profile List
Table Microecological Modulator Operating Data of United Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Gilead Sciences
Table Gilead Sciences Profile List
Table Microecological Modulator Operating Data of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Lung Biotechnology PBC
Table Lung Biotechnology PBC Profile List
Table Microecological Modulator Operating Data of Lung Biotechnology PBC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Pulmonary Hypertension Drugs
Table Products Segment of Pulmonary Hypertension Drugs
Table Global Pulmonary Hypertension Drugs Market by Type, 2011-2022 (USD Million)
Table Prostacyclin and prostacyclin analogs Overview
Table Endothelin receptor antagonists (ERAs) Overview
Table Phosphodiesterase-5 (PDE-5) inhibitors Overview
Table Soluble guanylate cyclase (sGC) stimulators Overview
Table Application Segment of Pulmonary Hypertension Drugs
Table Global Pulmonary Hypertension Drugs Market by Application, 2011-2022 (USD Million)
Table Early-stage Drug Candidates (Phase I & Phase II) Overview
Table Late-stage Drug Candidates (Phase III & Registration Phase) Overview
Table Global Pulmonary Hypertension Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Pulmonary Hypertension Drugs
Table Market Dynamics
Table Policy of Pulmonary Hypertension Drugs
Table GDP of Major Countries
Table Technology of Pulmonary Hypertension Drugs
Table Market Entry of Pulmonary Hypertension Drugs
Table Prostacyclin and prostacyclin analogs CAGR by Revenue and Volume, 2015-2019
Table Endothelin receptor antagonists (ERAs) CAGR by Revenue and Volume, 2015-2019
Table Phosphodiesterase-5 (PDE-5) inhibitors CAGR by Revenue and Volume, 2015-2019
Table Soluble guanylate cyclase (sGC) stimulators CAGR by Revenue and Volume, 2015-2019
Table Prostacyclin and prostacyclin analogs CAGR by Revenue and Volume, 2012-2024
Table Endothelin receptor antagonists (ERAs) CAGR by Revenue and Volume, 2012-2024
Table Phosphodiesterase-5 (PDE-5) inhibitors CAGR by Revenue and Volume, 2012-2024
Table Soluble guanylate cyclase (sGC) stimulators CAGR by Revenue and Volume, 2012-2024
Table Early-stage Drug Candidates (Phase I & Phase II) CAGR by Revenue and Volume, 2015-2019
Table Late-stage Drug Candidates (Phase III & Registration Phase) CAGR by Revenue and Volume, 2015-2019
Table Early-stage Drug Candidates (Phase I & Phase II) CAGR by Revenue and Volume, 2020-2025
Table Late-stage Drug Candidates (Phase III & Registration Phase) CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Pulmonary Hypertension Drugs Market by Vendors, 2015-2019 (in Volume)
Table Global Pulmonary Hypertension Drugs Market Share by Vendors, 2015-2019 (USD Million)
Table Global Pulmonary Hypertension Drugs Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table Bayer Profile List
Table Microecological Modulator Operating Data of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Profile List
Table Microecological Modulator Operating Data of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Arena Profile List
Table Microecological Modulator Operating Data of Arena (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Actelion Profile List
Table Microecological Modulator Operating Data of Actelion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Therapeutics Profile List
Table Microecological Modulator Operating Data of United Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Profile List
Table Microecological Modulator Operating Data of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lung Biotechnology PBC Profile List
Table Microecological Modulator Operating Data of Lung Biotechnology PBC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
